Cargando…

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients

PURPOSE: Tenofovir disoproxil fumarate is accepted as an effective and tolerable drug for treatment of HBV, similar to entecavir. However, there are some concerns about the nephrotoxicity of tenofovir. The aim of this study is to compare the renal-function change of liver recipients who received ten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sang Jin, Rhu, Jinsoo, Lee, Seo Hee, Kim, Jong Man, Choi, Gyu-Seong, Kim, Kyunga, Joh, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463039/ https://www.ncbi.nlm.nih.gov/pubmed/32908850 http://dx.doi.org/10.4174/astr.2020.99.3.180

Ejemplares similares

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Prediction model for early graft failure after liver transplantation using aspartate aminotransferase, total bilirubin and coagulation factor
por: Rhu, Jinsoo, et al.
Publicado: (2021)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
por: Kim, Kyeong Deok, et al.
Publicado: (2021)

Early use of everolimus improved renal function after adult deceased donor liver transplantation
por: Lee, Seohee, et al.
Publicado: (2021)

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021)

Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
por: Ha, Yeonjung, et al.
Publicado: (2020)

Hepatic venous territory mapping in living donor liver transplantation using right liver graft: an objective parameter for venous reconstruction
por: Yang, Jaehun, et al.
Publicado: (2023)

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
por: Yun, Sang Oh, et al.
Publicado: (2023)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

3D Printing Model of Abdominal Cavity of Liver Transplantation Recipient to Prevent Large-for-Size Syndrome
por: Park, Sunghae, et al.
Publicado: (2022)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience
por: Kim, Sang Jin, et al.
Publicado: (2021)

Early reoperation after adult living-donor liver transplantation is associated with poor survival
por: Lim, Manuel, et al.
Publicado: (2019)

Author Correction: The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Comparison of liver regeneration in laparoscopic versus open right hemihepatectomy for adult living donor liver transplantation
por: Yang, Jaehun, et al.
Publicado: (2020)

Laparoscopy of hepatocellular carcinoma is helpful in minimizing intra-abdominal adhesion during salvage transplantation
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
por: Kim, Jong Man, et al.
Publicado: (2022)

Postoperative Health Status and Quality of Life After Pure Laparoscopic Donor Hepatectomy for Living Donor Liver Transplantation
por: Cho, Chan Woo, et al.
Publicado: (2022)

Risk factors of silent allograft fibrosis 10 years post-pediatric liver transplantation
por: Rhu, Jinsoo, et al.
Publicado: (2020)

Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
por: Jo, Sung Jun, et al.
Publicado: (2022)

Tablet or capsule form of generic mycophenolate mofetil (My-Rept(®)) after liver transplantation: a prospective randomized trial
por: Kim, Jong Man, et al.
Publicado: (2019)

Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus
por: Lee, Ji Soo, et al.
Publicado: (2023)

Application of three-dimensional printing for intraoperative guidance during liver resection of a hepatocellular carcinoma with sophisticated location
por: Rhu, Jinsoo, et al.
Publicado: (2021)

Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
por: Baqai, Sumbella, et al.
Publicado: (2015)

Intraoperative Ultrasonography as a Guidance for Dividing Bile Duct During Laparoscopic Living Donor Hepatectomy
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
por: Lee, Sung Won, et al.
Publicado: (2021)

Elderly Hepatocellular Carcinoma Patients: Open or Laparoscopic Approach?
por: Kim, Jong Man, et al.
Publicado: (2020)

Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naïve Chronic Hepatitis B patients
por: Yu, Hyung Min, et al.
Publicado: (2015)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
por: Yang, Young-Mo, et al.
Publicado: (2017)

Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis
por: Lee, Hyo-Young, et al.
Publicado: (2019)

Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study
por: Oh, Young Ju, et al.
Publicado: (2023)

Feasibility of laparoscopic liver resection for liver cavernous hemangioma: A single-institutional comparative study
por: Shin, Younghuen, et al.
Publicado: (2020)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
por: Woo, Hyun Young, et al.
Publicado: (2020)

Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients
por: Park, Ji Won, et al.
Publicado: (2017)

Upper thigh skeletal muscle index predicts outcomes in liver transplant recipients
por: Lim, Manuel, et al.
Publicado: (2023)

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
por: Jeon, Hee-Jeong, et al.
Publicado: (2017)

Automated 3D liver segmentation from hepatobiliary phase MRI for enhanced preoperative planning
por: Oh, Namkee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5mhar5dr15cckut28fejs3veqf